Analyst Consensus ?
ConsensusHold39 ratings
Bullish1743.6%
Neutral1641.0%
Bearish615.4%
FN2 Earnings Intelligence
Molina Healthcare, Inc. (MOH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 28, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 24, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 24, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jul 24, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 14, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jun 8, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 4, 2026 |
| UBS | Neutral | Neutral | Maintain | May 22, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | May 11, 2026 |
| Baird | Neutral | Neutral | Maintain | May 11, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Mar 12, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Feb 12, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 5, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Feb 6, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 29, 2024 |
| Jefferies | Hold | Hold | Maintain | Jul 24, 2024 |
| B of A Securities | Underperform | Neutral | Downgrade | Apr 1, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 28, 2023 |
| Loop Capital | Hold | Hold | Maintain | Jun 17, 2022 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 14, 2022 |
| SVB Leerink | Outperform | Outperform | Maintain | Oct 30, 2020 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jun 16, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 4, 2020 |
| Piper Sandler | Overweight | Overweight | Maintain | May 4, 2020 |
| CFRA | Buy | Hold | Upgrade | May 4, 2020 |
| Bank of America | Underperform | Underperform | Maintain | Aug 1, 2018 |
| Mitsubishi UFJ | Neutral | Neutral | Maintain | Sep 21, 2017 |
| Stifel Nicolaus | Sell | Hold | Downgrade | May 31, 2017 |
| Stifel | Sell | Hold | Downgrade | May 31, 2017 |
| Wolfe Research | Perform | Market Perform | Maintain | May 8, 2017 |
| PiperJaffray | Overweight | Overweight | Maintain | Jan 4, 2017 |
| Leerink Swann | Outperform | Outperform | Maintain | May 2, 2016 |
| Susquehanna | Positive | Positive | Maintain | Sep 18, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Jun 27, 2014 |
| Monness, Crespi, Hardt | Buy | Buy | Maintain | May 2, 2014 |
| Monness Crespi Hardt | Buy | Buy | Maintain | May 2, 2014 |
| Wedbush | Outperform | Outperform | Maintain | Mar 14, 2013 |
| Citigroup | Buy | Buy | Maintain | Apr 9, 2012 |
| Bank oferica | Underperform | Underperform | Maintain | Feb 24, 2012 |
Upside is calculated against the persisted current price $195.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $220 | $199.48 | +12.5% | Jul 28, 2026 |
| RBC Capital | Ben Hendrix | $218 | $195.8 | +11.4% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $180 | $200.29 | -8.0% | Jul 24, 2026 |
| Truist Financial | Analyst unavailable | $250 | $242.88 | +27.8% | Jul 14, 2026 |
| Jefferies | Analyst unavailable | $230 | $242.88 | +17.6% | Jul 14, 2026 |
| Wells Fargo | Analyst unavailable | $235 | $233.31 | +20.1% | Jul 13, 2026 |
| Bernstein | Analyst unavailable | $286 | $233.31 | +46.2% | Jul 13, 2026 |
| RBC Capital | Ben Hendrix | $248 | $233.43 | +26.8% | Jul 9, 2026 |
| Barclays | Andrew Mok | $184 | $232.9 | -5.9% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $216 | $197.42 | +10.4% | Jun 23, 2026 |
| Mizuho Securities | Analyst unavailable | $215 | $190.86 | +9.9% | Jun 8, 2026 |
| Morgan Stanley | Analyst unavailable | $167 | $184.82 | -14.6% | Jun 4, 2026 |
| Barclays | Andrew Mok | $199 | $175.59 | +1.7% | May 26, 2026 |
| UBS | Analyst unavailable | $202 | $181.26 | +3.3% | May 22, 2026 |
| Truist Financial | Analyst unavailable | $205 | $186.49 | +4.8% | May 11, 2026 |
| Robert W. Baird | Michael Ha | $163 | $185.94 | -16.7% | May 11, 2026 |
| Truist Financial | Analyst unavailable | $180 | $176.89 | -8.0% | Apr 27, 2026 |
| Wells Fargo | Stephen Baxter | $159 | $175.94 | -18.7% | Apr 27, 2026 |
| Deutsche Bank | George Hill | $129 | $168.3 | -34.1% | Apr 24, 2026 |
| UBS | Analyst unavailable | $180 | $168.09 | -8.0% | Apr 24, 2026 |
| Morgan Stanley | Analyst unavailable | $146 | $169.9 | -25.4% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $161 | $174.51 | -17.7% | Apr 24, 2026 |
| UBS | Analyst unavailable | $173 | $148.78 | -11.6% | Mar 13, 2026 |
| Wells Fargo | Stephen Baxter | $141 | $148.24 | -27.9% | Feb 20, 2026 |
| Truist Financial | Analyst unavailable | $145 | $134.1 | -25.9% | Feb 17, 2026 |
| Goldman Sachs | Analyst unavailable | $124 | $122.65 | -36.6% | Feb 11, 2026 |
| Deutsche Bank | Analyst unavailable | $109 | $128.47 | -44.3% | Feb 10, 2026 |
| Barclays | Andrew Mok | $133 | $127.53 | -32.0% | Feb 10, 2026 |
| UBS | Analyst unavailable | $145 | $126.71 | -25.9% | Feb 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $144 | $128.79 | -26.4% | Feb 9, 2026 |
| Mizuho Securities | Ann Hynes | $220 | $183.5 | +12.5% | Jan 9, 2026 |
| Wells Fargo | Stephen Baxter | $208 | $184.73 | +6.3% | Jan 7, 2026 |
| Bernstein | Analyst unavailable | $224 | $184.04 | +14.5% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $164 | $178.46 | -16.2% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $160 | $163.42 | -18.2% | Dec 16, 2025 |
| Truist Financial | Analyst unavailable | $175 | $164.13 | -10.5% | Oct 24, 2025 |
| Morgan Stanley | Erin Wright | $158 | $161 | -19.2% | Oct 24, 2025 |
| UBS | Analyst unavailable | $170 | $161 | -13.1% | Oct 24, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $180 | $161 | -8.0% | Oct 24, 2025 |
| Goldman Sachs | Scott Fidel | $167 | $161 | -14.6% | Oct 24, 2025 |
| Deutsche Bank | Analyst unavailable | $165 | $163.73 | -15.7% | Oct 24, 2025 |
| Truist Financial | Analyst unavailable | $210 | $194.37 | +7.4% | Oct 14, 2025 |
| Morgan Stanley | Analyst unavailable | $204 | $193.76 | +4.3% | Oct 14, 2025 |
| Goldman Sachs | Scott Fidel | $207 | $194.27 | +5.8% | Oct 14, 2025 |
| Wells Fargo | Analyst unavailable | $231 | $200.57 | +18.1% | Oct 7, 2025 |
| Mizuho Securities | Ann Hynes | $330 | $221.55 | +68.7% | Jul 11, 2025 |
| Morgan Stanley | Erin Wright | $266 | $228.58 | +36.0% | Jul 10, 2025 |
| Morgan Stanley | Erin Wright | $364 | $297 | +86.1% | Jun 9, 2025 |
| Robert W. Baird | Michael Ha | $375 | $335.5 | +91.7% | Apr 15, 2025 |
| Wells Fargo | Analyst unavailable | $372 | $311.89 | +90.2% | Mar 5, 2025 |
| Mizuho Securities | Analyst unavailable | $376 | $302.84 | +92.2% | Mar 3, 2025 |
| Robert W. Baird | Michael Ha | $331 | $275 | +69.2% | Oct 24, 2024 |
| Wells Fargo | Stephen Baxter | $360 | $346.97 | +84.0% | Aug 5, 2024 |
| Jefferies | David Windley | $297 | $286.9 | +51.8% | Jul 24, 2024 |
| Truist Financial | David MacDonald | $400 | $292.84 | +104.5% | Jul 15, 2024 |
| Robert W. Baird | Michael Ha | $405 | $315 | +107.0% | May 29, 2024 |
| Barclays | Andrew Mok | $430 | $367.41 | +119.8% | Apr 25, 2024 |
| Wells Fargo | Stephen Baxter | $410 | $376.57 | +109.6% | Apr 15, 2024 |
| Wells Fargo | Stephen Baxter | $420 | $398.14 | +114.7% | Feb 15, 2024 |
| Barclays | Analyst unavailable | $375 | $318.92 | +91.7% | Jan 4, 2023 |
| Wells Fargo | Analyst unavailable | $340 | $318.92 | +73.8% | Jan 3, 2023 |
| Wells Fargo | Analyst unavailable | $345 | $327.5 | +76.4% | Aug 26, 2022 |
| Mizuho Securities | Analyst unavailable | $366 | $318.19 | +87.1% | Jul 29, 2022 |
| Barclays | Analyst unavailable | $380 | $319.47 | +94.3% | Jul 29, 2022 |
| Wells Fargo | Analyst unavailable | $301 | $312.59 | +53.9% | May 25, 2022 |
| Deutsche Bank | Analyst unavailable | $311 | $306.08 | +59.0% | May 2, 2022 |
| Stephens | Scott Fidel | $300 | $295.72 | +53.4% | Oct 29, 2021 |
| Barclays | Steven Valiquette | $340 | $295.72 | +73.8% | Oct 29, 2021 |
| Jefferies | David Windley | $253 | $244.16 | +29.3% | Apr 14, 2021 |
Track every rating change on MOH the moment it posts. Free to start.
Start free